Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase

被引:18
|
作者
Fan, NS
Rank, KB
Poppe, SM
Tarpley, WG
Sharma, SK
机构
[1] UPJOHN CO,UPJOHN LABS,BIOCHEM,KALAMAZOO,MI 49001
[2] UPJOHN CO,UPJOHN LABS,CAN & INFECT DIS RES,KALAMAZOO,MI 49001
关键词
D O I
10.1021/bi9516440
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently we demonstrated that the p58 subunit of p68/p58 HIV-2 reverse transcriptase (RT) heterodimer, produced by processing of p68/p68 homodimer with recombinant HIV-2 protease, terminates at Met(484) [Fan, N., et al. (1995) J. Biol. Chem. 270, 13573-13579]. Here we describe purification and characterization of the p68/p58 heterodimer of recombinant HIV-2 RT. It exhibited both RT and RNase H activities, obeyed Michaelis-Menten kinetics, and was competitively inhibited by the DNA chain terminator ddTTP (K-i[app] = 305 +/- 20 nM). The HIV-2 RT-associated RNase H exhibited a marked preference for RNA hydrolysis from a HIV-1 gag-based heteropolymeric RNA/DNA hybrid in the presence of either Mg2+ or Mn2+, compared to the [H-3]poly(rA). poly(dT) or [H-3]poly(rG). poly(dC) homopolymeric substrates. Relative to HIV-1 RT, the RNase H activity of HIV-2 RT was only 5% toward the [H-3]poly(rA) poly(dT) in the presence of Mg2+. The size distribution of products generated from [H-3]poly(rA). poly(dT) by HIV-2 RT-associated RNase H was markedly distinct from that of HIV-1 RT in the presence of Mg2+ Or Mn2+. The p68/p58 HIV-2 RT heterodimer, produced by specific cleavage using HIV-2 protease, should be useful for inhibition and biophysical studies aimed at discovering and designing drugs directed toward HIV-2.
引用
收藏
页码:1911 / 1917
页数:7
相关论文
共 50 条
  • [1] Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer
    Wapling, J
    Moore, KL
    Sonza, S
    Mak, J
    Tachedjian, G
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10247 - 10257
  • [2] Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase
    LeGrice, SFJ
    Cameron, CE
    Benkovic, SJ
    DNA REPLICATION, 1995, 262 : 130 - 144
  • [3] HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE-TRANSCRIPTASE HETERODIMER STABILITY
    LEBOWITZ, J
    KAR, S
    BRASWELL, E
    MCPHERSON, S
    RICHARD, DL
    PROTEIN SCIENCE, 1994, 3 (09) : 1374 - 1382
  • [4] Human immunodeficiency virus type 1 reverse transcriptase
    Hottiger, M
    Hubscher, U
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1996, 377 (02): : 97 - 120
  • [5] PURIFICATION AND PARTIAL CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 REVERSE-TRANSCRIPTASE
    DEVICO, AL
    COPELAND, TD
    VERONESE, FD
    OROSZLAN, S
    GALLO, RC
    SARNGADHARAN, MG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (01) : 51 - 60
  • [6] STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE HETERODIMER
    WANG, J
    SMERDON, SJ
    JAGER, J
    KOHLSTAEDT, LA
    RICE, PA
    FRIEDMAN, JM
    STEITZ, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) : 7242 - 7246
  • [7] Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate
    QuinonesMateu, ME
    Soriano, V
    Domingo, E
    MenendezArias, L
    VIROLOGY, 1997, 236 (02) : 364 - 373
  • [8] p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase
    Mary Bakhanashvili
    Oncogene, 2001, 20 : 7635 - 7644
  • [9] p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase
    Bakhanashvili, M
    ONCOGENE, 2001, 20 (52) : 7635 - 7644
  • [10] Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase for Use in cDNA Synthesis
    Atsushi Konishi
    Mayu Shinomura
    Kiyoshi Yasukawa
    Applied Biochemistry and Biotechnology, 2013, 169 : 77 - 87